The present invention concerns a composition, a pharmaceutical one and/or a dietary supplement, for treatment use of metabolic disorders derived from or connected with the metabolic of insulin-resistance syndrome, that is hyperinsulinemia, diabetes, hyperglycemia, steatosis, cirrhosis, hyperlipidemia, atherosclerosis and cardiovascular risk.